A pharmacokinetic study evaluating drug interactions between boceprevir and ritonavir-boosted HIV protease inhibitors in healthy volunteers.

Trial Profile

A pharmacokinetic study evaluating drug interactions between boceprevir and ritonavir-boosted HIV protease inhibitors in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Nov 2012

At a glance

  • Drugs Boceprevir (Primary) ; Atazanavir/ritonavir; Darunavir; Lopinavir/ritonavir; Ritonavir
  • Indications Hepatitis C; HIV infections
  • Focus Pharmacokinetics
  • Sponsors Merck & Co
  • Most Recent Events

    • 09 Mar 2012 The trial title is not an official title
    • 06 Mar 2012 Results from this study were presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI), according to a Merck and Co. media release
    • 06 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top